Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Targeting Ang-2 for inflammatory vasculopathies

March 13, 2006

Miraxion improves stress hormone transport through the blood-brain barrier

March 13, 2006

Receptor occupancy, pharmacokinetics and safety of lecozotan forms investigated

March 13, 2006

Novel analgesic agents disclosed in recent patent literature

March 10, 2006

Nonapprovable letter for Vadova

March 10, 2006

Phase II study of DP-b99 in acute stroke cleared to continue

March 10, 2006

RB-101: antidepressant without associated convulsions

March 9, 2006

FDA Advisory Committee recommends return of Tysabri to market

March 9, 2006

Neuren cleared to advance NNZ-2566 into phase I for traumatic brain injury

March 9, 2006

Phase II pagoclone study in stuttering completes enrollment

March 9, 2006

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...